{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T12:34:41Z","timestamp":1759667681898},"reference-count":17,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.3892\/mco.2014.359","type":"journal-article","created":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T11:32:39Z","timestamp":1406201559000},"page":"953-959","source":"Crossref","is-referenced-by-count":7,"title":["Rechallenge with pemetrexed-based chemotherapy improves the survival of patients with advanced non-squamous non-small-cell lung cancer"],"prefix":"10.3892","volume":"2","author":[{"given":"MING-LEI","family":"ZHUO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HUA","family":"BAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHI-JIE","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIAN-CHUN","family":"DUAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TONG-TONG","family":"AN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MEI-NA","family":"WU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUN","family":"ZHAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YU-YAN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHU-HANG","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIE","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,7,24]]},"reference":[{"key":"key20180107151117_b1-mco-02-06-0953","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","article-title":"Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer","volume":"26","author":"Scagliotti","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180107151117_b2-mco-02-06-0953","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1200\/JCO.2004.08.163","article-title":"Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy","volume":"22","author":"Hanna","year":"2004","journal-title":"J Clin Oncol"},{"key":"key20180107151117_b3-mco-02-06-0953","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20180107151117_b4-mco-02-06-0953","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.lungcan.2010.12.004","article-title":"Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma","volume":"72","author":"Ceresoli","year":"2011","journal-title":"Lung Cancer"},{"key":"key20180107151117_b5-mco-02-06-0953","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.lungcan.2011.08.011","article-title":"Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter survey","volume":"75","author":"Zucali","year":"2012","journal-title":"Lung Cancer"},{"key":"key20180107151117_b6-mco-02-06-0953","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/1756-0500-5-482","article-title":"Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience","volume":"5","author":"Bearz","year":"2012","journal-title":"BMC Res Notes"},{"key":"key20180107151117_b7-mco-02-06-0953","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"key20180107151117_b8-mco-02-06-0953","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1200\/JCO.2011.39.3744","article-title":"Influence of chemotherapy on EGFR mutation status among patients with non-small-cell lung cancer","volume":"30","author":"Bai","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20180107151117_b9-mco-02-06-0953","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.lungcan.2011.01.024","article-title":"Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: the association with treatment efficacy of pemetrexed","volume":"74","author":"Chen","year":"2011","journal-title":"Lung Cancer"},{"key":"key20180107151117_b10-mco-02-06-0953","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/JTO.0b013e318260deaa","article-title":"Folylpoly-glutamate synthetase expression is associated with tumor response and outcome from pemetrexed-based chemotherapy in malignant pleural mesothelioma","volume":"7","author":"Christoph","year":"2012","journal-title":"J Thorac Oncol"},{"key":"key20180107151117_b11-mco-02-06-0953","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1158\/1078-0432.CCR-09-1641","article-title":"Differential thymidylate synthase expression in different variants of large-cell carcinoma of the lung","volume":"15","author":"Monica","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"Suppl 6","key":"key20180107151117_b12-mco-02-06-0953","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1053\/j.seminoncol.2006.03.012","article-title":"Management of platinum-sensitive recurrent ovarian cancer","volume":"33","author":"Pfisterer","year":"2006","journal-title":"Semin Oncol"},{"key":"key20180107151117_b13-mco-02-06-0953","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.lungcan.2010.09.009","article-title":"Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: A multi-institutional retrospective analysis","volume":"72","author":"Garassino","year":"2011","journal-title":"Lung Cancer"},{"key":"key20180107151117_b14-mco-02-06-0953","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1200\/JCO.2012.47.1102","article-title":"PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer","volume":"31","author":"Paz-Ares","year":"2013","journal-title":"J Clin Oncol"},{"key":"key20180107151117_b15-mco-02-06-0953","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1200\/JCO.2012.42.3749","article-title":"Randomized phase III trial of maintenance bevacizumab with or without pemetrexed after first-line induction with bevacizumab, cisplatin, and pemetrexed in advanced nonsquamous non-small-cell lung cancer: AVAPERL (MO22089)","volume":"31","author":"Barlesi","year":"2013","journal-title":"J Clin Oncol"},{"key":"key20180107151117_b16-mco-02-06-0953","first-page":"3327","article-title":"Pemetrexed and cisplatin for advanced non-squamous non-small cell lung cancer in Japanese patients: phase II study","volume":"33","author":"Kawano","year":"2013","journal-title":"Anticancer Res"},{"key":"key20180107151117_b17-mco-02-06-0953","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.biopha.2013.04.013","article-title":"Pemetrexed as the first-line therapy for Chinese patients with advanced non-squamous non-small-cell lung cancer","volume":"67","author":"Xu","year":"2013","journal-title":"Biomed Pharmacother"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2014.359\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T15:11:28Z","timestamp":1515337888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2014.359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,24]]},"references-count":17,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,7,24]]},"published-print":{"date-parts":[[2014,11]]}},"alternative-id":["10.3892\/mco.2014.359"],"URL":"https:\/\/doi.org\/10.3892\/mco.2014.359","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,24]]}}}